Literature DB >> 20514026

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways.

F E Lock1, N Underhill-Day, T Dunwell, D Matallanas, W Cooper, L Hesson, A Recino, A Ward, T Pavlova, E Zabarovsky, M M Grant, E R Maher, A D Chalmers, W Kolch, F Latif.   

Abstract

The Ras-assocation domain family (RASSF) of tumor suppressor proteins until recently contained six proteins named RASSF1-6. Recently, four novel family members, RASSF7-10, have been identified by homology searches for RA-domain-containing proteins. These additional RASSF members are divergent and structurally distinct from RASSF1-6, containing an N-terminal RA domain and lacking the Sav/RASSF/Hpo (SARAH) domain. Here, we show that RASSF8 is ubiquitously expressed throughout the murine embryo and in normal human adult tissues. Functionally, RNAi-mediated knockdown of RASSF8 in non-small-cell lung cancer (NSCLC) cell lines, increased anchorage-independent growth in soft agar and enhanced tumor growth in severe combined immunodeficiency (SCID) mice. Furthermore, EdU staining of RASSF8-depleted cells showed growth suppression in a manner dependent on contact inhibition. We show that endogenous RASSF8 is not only found in the nucleus, but is also membrane associated at sites of cell-cell adhesion, co-localizing with the adherens junction (AJ) component beta-catenin and binding to E-cadherin. Following RASSF8 depletion in two different lung cancer cell lines using alternative small interfering RNA (siRNA) sequences, we show that AJs are destabilized and E-cadherin is lost from the cell membrane. The AJ components beta-catenin and p65 are also lost from sites of cell-cell contact and are relocalized to the nucleus with a concomitant increase in beta-catenin-dependent and nuclear factor-kappaB (NF-kappaB)-dependent signaling following RASSF8 depletion. RASSF8 may also be required to maintain actin -cytoskeletal organization since immunofluorescence analysis shows a striking disorganization of the actin- cytoskeleton following RASSF8 depletion. Accordingly, scratch wound healing studies show increased cellular migration in RASSF8-deficient cells. These results implicate RASSF8 as a tumor suppressor gene that is essential for maintaining AJs function in epithelial cells and have a role in epithelial cell migration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514026     DOI: 10.1038/onc.2010.192

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

Review 1.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

2.  Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons.

Authors:  Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Alexey V Tkach; Ashley R Murray; Ann Hubbs; Madalina M Chirila; Phouthone Keohavong; Lyudmila P Sycheva; Valerian E Kagan; Vincent Castranova
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

3.  E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases.

Authors:  Isai Pratha Karthik; Pavitra Desai; Sudarkodi Sukumar; Aleksandra Dimitrijevic; Krishnaraj Rajalingam; Sundarasamy Mahalingam
Journal:  J Biol Chem       Date:  2018-02-21       Impact factor: 5.157

Review 4.  Adherens Junction and E-Cadherin complex regulation by epithelial polarity.

Authors:  Peter Coopman; Alexandre Djiane
Journal:  Cell Mol Life Sci       Date:  2016-05-05       Impact factor: 9.261

5.  Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice.

Authors:  Hoogeun Song; Hyunsoo Kim; Kyunghee Lee; Da-Hye Lee; Tae-Shin Kim; Ji Yun Song; Dongjun Lee; Dongwook Choi; Chang-Yong Ko; Han-Sung Kim; Hong-In Shin; Juhyun Choi; Heedong Park; Chankyu Park; Daewon Jeong; Dae-Sik Lim
Journal:  EMBO J       Date:  2012-01-06       Impact factor: 11.598

6.  Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis.

Authors:  Asha Recino; Victoria Sherwood; Amy Flaxman; Wendy N Cooper; Farida Latif; Andrew Ward; Andrew D Chalmers
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

Review 7.  N-terminal RASSF family: RASSF7-RASSF10.

Authors:  Nicholas Underhill-Day; Victoria Hill; Farida Latif
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 8.  Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma.

Authors:  Meina Jiang; Shuai Fang; Xiaodong Zhao; Chengwei Zhou; Zhaohui Gong
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

9.  The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.

Authors:  Anna Djos; Tommy Martinsson; Per Kogner; Helena Carén
Journal:  Mol Cancer       Date:  2012-06-13       Impact factor: 27.401

10.  Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.

Authors:  Jennifer Clark; Jessica Freeman; Howard Donninger
Journal:  Mol Biol Int       Date:  2012-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.